Loomis, Sayles & Company
NPSP

Loomis, Sayles & Company’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Loomis, Sayles & Company’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-660,287
Closed -$20M – 806
2013
Q4 		$20M Buy
660,287
+19,859
+3% +$547K 0.06% 354
2013
Q3 		$20.4M Sell
640,428
-234,851
-27% -$5.39M 0.07% 314
2013
Q2 		$13.2K Buy
+875,279
New +$12.1M 0.05% 417

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company's NPSP Position: Q1 2014 in Review

Loomis, Sayles & Company sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2014, closing a stake of 660,287 shares — an estimated $20M sold.

Loomis, Sayles & Company first reported a position in NPSP in Q2 2013 and held it in 3 quarters. The position peaked at $20.4M in Q3 2013. 210 funds tracked by Wall St. Rank hold NPSP as of Q1 2014.

  • Loomis, Sayles & Company reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Loomis, Sayles & Company sold 660,287 NPS PHARMACEUTICALS INC shares in Q1 2014, an estimated $20M.
  • Loomis, Sayles & Company first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Loomis, Sayles & Company's NPS PHARMACEUTICALS INC position peaked at $20.4M in Q3 2013.
  • 210 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2014.

Based on Loomis, Sayles & Company's 13F filing for Q1 2014, filed 15 May 2014.